CompoAtlas

Acide linoléique conjugué in food supplements

278 supplements declared in France contain Acide linoléique conjugué as a substance or active ingredient.

Other names in the Compl'Alim list: CLA.

Compl'Alim declarations. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

In plain words

À quoi il sert, selon les fabricants

Objectifs les plus souvent annoncés pour les compléments qui en contiennent (Acide linoléique conjugué) : sport (109 produits), minceur / brûleur (62 produits), gestion du poids / minceur (31 produits), minceur / ventre plat (18 produits), minceur / modérateur d'appétit (14 produits).

Ce sont les objectifs déclarés par les fabricants à l'administration, pas des effets démontrés. Sur l'emballage, seules les allégations de santé autorisées par l'Union peuvent être écrites.

What the registers say, country by country

Each line repeats what an official register says on the date it was consulted. Not being in a register means neither allowed nor banned.

Health claims register (European Union): 0 authorised and 8 refused claim(s) for this substance.

EU Register of nutrition and health claims, retrieved 21 October 2026.

Compl'Alim ingredient list (France): listed.

Compl'Alim, reference list of ingredients, retrieved 21 October 2026.

Canada, licensed natural health products (LNHPD): 330 products.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

United States, supplement labels (DSLD; supplements need no prior approval): 26 products.

Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

Poland, notified supplements: 175 products.

GIS, products notified in Poland, retrieved 27 October 2026.

Główny Inspektorat Sanitarny (GIS), Rejestr produktów objętych powiadomieniem

CC BY 4.0

United States, supplements listed by the USDA: 7 products.

USDA FoodData Central Branded, supplement cohort, retrieved 29 October 2026.

Source : U.S. Department of Agriculture, Agricultural Research Service, FoodData Central, Branded Foods. Données publiées sous CC0 1.0 Universal, https://creativecommons.org/publicdomain/zero/1.0/.

CC0 1.0 Universal, domaine public

Declared daily quantities

Declared daily quantities: Acide linoléique conjugué
UnitProductsMedianMinimumMaximum
mg7234704,000

Calculated from Compl'Alim declarations that provide a quantity. These are quantities declared by manufacturers, not measurements, and preparation is not distinguished (powder, extract of varying concentration): differences between products can be very large.

Official warnings (Health Canada)

CONJUGATED LINOLEIC ACID

Route of administration: Oral

Cautions and warnings

Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are obese or have cardiovascular disease (CVD) risk factors (Tholstrup et al. 2008; Gaullier et al. 2007; Steck et al. 2007; Larsen et al. 2006; Taylor et al. 2006; Gaullier et al. 2005; Smedman et al. 2005; Gaullier et al. 2004; Basu et al. 2000a,b).

Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if your goal is to achieve weight loss.

Contraindications

Do not use if you are pregnant (HC 2010).

Do not use if you have cardiovascular disease (CVD), diabetes, metabolic syndrome or insulin resistance (Tholstrup et al. 2008; Gaullier et al. 2007; Steck et al. 2007; Larsen et al. 2006; Taylor et al. 2006; Gaullier et al. 2005; Smedman et al. 2005; Gaullier et al. 2004; Moloney et al. 2004; Basu et al. 2000a,b).

Known adverse reactions

When using this product you may experience gastrointestinal discomfort/disturbances (Gaullier et al. 2007; Pinkoski et al. 2006; Berven et al. 2000; Blankson et al. 2000).

Health Canada monograph dated 10 January 2025

Texts from the monograph of Health Canada, the Canadian authority, reproduced without modification. They do not replace medical advice.

Products

Enter to analyse, Shift+Enter for a new line